BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1054727)

  • 1. Counter-electrophoresis as a possible method for typing ECHO and Coxsackie B viruses.
    MacWilliam KM; Cook KM
    J Hyg (Lond); 1975 Apr; 74(2):239-44. PubMed ID: 1054727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of antibodies against Coxsackie A, B and Echo viruses in human sera by the method of two-dimensional immunodiffusion on agar gel. I. Precipitating antibodies against Coxackie viruses group B].
    Dupková E
    Cesk Epidemiol Mikrobiol Imunol; 1975 Sep; 24(5):270-4. PubMed ID: 129288
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquisition of antibodies to various Coxsackie and Echo viruses and hepatitis A virus in agricultural communal settlements in Israel.
    Morag A; Margalith M; Shuval HI; Fattal B
    J Med Virol; 1984; 14(1):39-47. PubMed ID: 6747611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A latex agglutination test for typing enteroviruses (author's transl)].
    Schmidt WA; Klein M
    Arch Gesamte Virusforsch; 1973; 43(3):213-20. PubMed ID: 4359176
    [No Abstract]   [Full Text] [Related]  

  • 5. Enterovirus IgM detection: specificity of mu-antibody-capture radioimmunoassays using virions and procapsids of Coxsackie B virus.
    Frisk G; Nilsson E; Ehrnst A; Diderholm H
    J Virol Methods; 1989; 24(1-2):191-202. PubMed ID: 2547815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of enterovirus neutralization by treatment with sodium deoxycholate or chloroform.
    Kapsenberg JG; Ras A; Korte J
    Intervirology; 1980; 12(6):329-34. PubMed ID: 6244237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inactivated combined Coxsackie A-9 and B-1 as well as Echo-6 vaccine. II. Immunogenicity of the combined vaccine].
    Biernacki M; Jabloński L
    Med Dosw Mikrobiol; 1974; 26(4):347-50. PubMed ID: 4475337
    [No Abstract]   [Full Text] [Related]  

  • 8. [Persistence of latex agglutination inhibition antibodies in rabbits following application of poliomyelitis-, Coxsackie-, Echo- and encephalomyocarditis viruses. Brief report].
    Schmidt WA; Brade H; Klein M
    Arch Virol; 1975; 47(3):291-4. PubMed ID: 164163
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
    Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
    Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of Coxsackie B viruses in the etiology of dilated cardiomyopathy].
    Shirobokov VP; Amosova EN; Korniushenko ON; Evtushenko AI; Krivolap VI
    Ter Arkh; 1990; 62(3):107-10. PubMed ID: 2164261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of the antigenic components of Coxsackie and ECHO viruses and their antibodies].
    Schmidt WA
    Arch Gesamte Virusforsch; 1971; 33(1):77-87. PubMed ID: 4325978
    [No Abstract]   [Full Text] [Related]  

  • 12. Tests for coxsackie B virus-specific IgM.
    Pattison JR
    J Hyg (Lond); 1983 Jun; 90(3):327-32. PubMed ID: 6306096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quick antiserum preparation for the virus CF-test. Immunisation of rats with enteroviruses (ECHO and Coxsackie) and respiratory syncytial (RS) viruses].
    Adam D
    Zentralbl Bakteriol Orig; 1970 May; 213(4):470-8. PubMed ID: 5455470
    [No Abstract]   [Full Text] [Related]  

  • 14. [Age distribution of neutralizing antibodies against Coxsackie and ECHO viruses among inhabitants of the Morioka area].
    Kawana R; Kaneko M
    Igaku To Seibutsugaku; 1965 Dec; 71(6):373-7. PubMed ID: 5895001
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inactivated combined Coxsackie A-9 and B-1 as well as Echo-6 vaccine. I. Basic studies].
    Biernacki M; Jabloński L
    Med Dosw Mikrobiol; 1974; 26(4):339-45. PubMed ID: 4444375
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isolation of enteroviruses from patients with clinical manifestations of poliomyelitis].
    Spynu KI; Vutkarev VP
    Vopr Virusol; 1983; 28(6):686-9. PubMed ID: 6322453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation of Coxsackie A viruses from the intestine of the house mouse].
    Kiseleva NV; Petrov BV; Berdyliev OM
    Vopr Virusol; 1972; 17(6):713-6. PubMed ID: 4268535
    [No Abstract]   [Full Text] [Related]  

  • 18. Subclassification of enteroviruses and ECHO virus type 34. Brief report.
    Rosen L; Melnick JL; Schmidt J; Wenner HA
    Arch Gesamte Virusforsch; 1970; 30(1):89-92. PubMed ID: 4986680
    [No Abstract]   [Full Text] [Related]  

  • 19. Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies.
    Yagi S; Schnurr D; Lin J
    J Clin Microbiol; 1992 Sep; 30(9):2498-501. PubMed ID: 1328290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies against enterovirus (ECHO virus 7, 11, 12 and coxsackie virus B 3) of the inhabitants of Okinawa and South-Western islands in Pacific ocean].
    Higashi T
    Kumamoto Igakkai Zasshi; 1971 May; 45(5):588-624. PubMed ID: 5171705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.